LONDON, Oct. 04, 2022 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today the agenda for its virtual Capital Markets Day on 12 October 2022 at 8:00 am ET (1 pm UK). Topics to be covered at the event span the design of the Phase 3 program for COMP360 psilocybin…


Previous articleMindset Pharma Selects Lead Clinical Candidates From “Family 2” of its Next Generation Psychedelic Drug Portfolio
Next articleSilo Pharma to Present at the Dawson James Small Cap Growth Conference on October 12